• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体出血中行早期与晚期玻璃体切除术的系统评价

Early versus Late Pars Plana Vitrectomy in Vitreous Hemorrhage: A Systematic Review.

作者信息

Confalonieri Filippo, Barone Gianmaria, Ferraro Vanessa, Ambrosini Giacomo, Gaeta Alessandro, Petrovski Beáta Éva, Lumi Xhevat, Petrovski Goran, Di Maria Alessandra

机构信息

Department of Ophthalmology, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.

Department of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.

出版信息

J Clin Med. 2023 Oct 20;12(20):6652. doi: 10.3390/jcm12206652.

DOI:10.3390/jcm12206652
PMID:37892789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10607253/
Abstract

: Vitreous hemorrhage (VH) is a common vitreoretinal condition causing impairment of vision due to various etiologies. No consensus exists on the best timing for performing pars plana vitrectomy (PPV) in fundus-obscuring VH. : Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards, we conducted a systematic review of the timing of PPV in VH. We assessed the strength of the evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach for all the included publications, in accordance with the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) recommendations. : A total of 1731 articles were identified. Following the removal of duplicates and screening of abstracts, 1203 articles remained. Subsequently, a comprehensive full-text review of 30 articles was conducted. Ultimately, 18 articles met the predefined inclusion criteria. : Despite the small number of studies on the timing of treatment for VH, the advantage of early over late PPV seems to be a reasonable approach in selected cases, and it might be considered modern standard care.

摘要

玻璃体积血(VH)是一种常见的玻璃体视网膜疾病,由于多种病因导致视力受损。对于眼底模糊的玻璃体积血患者,行玻璃体切割术(PPV)的最佳时机尚无共识。:按照系统评价和Meta分析的首选报告项目(PRISMA)标准,我们对玻璃体积血中行PPV的时机进行了系统评价。我们根据2011年牛津循证医学中心(OCEBM)的建议,采用推荐分级的评估、制定和评价(GRADE)方法对所有纳入的出版物评估证据强度。:共检索到1731篇文章。去除重复文献并筛选摘要后,剩余1203篇文章。随后,对30篇文章进行了全面的全文综述。最终,18篇文章符合预先设定的纳入标准。:尽管关于玻璃体积血治疗时机的研究数量较少,但在某些特定病例中,早期PPV优于晚期PPV似乎是一种合理的方法,并且可被视为现代标准治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e278/10607253/37b25e11be5e/jcm-12-06652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e278/10607253/37b25e11be5e/jcm-12-06652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e278/10607253/37b25e11be5e/jcm-12-06652-g001.jpg

相似文献

1
Early versus Late Pars Plana Vitrectomy in Vitreous Hemorrhage: A Systematic Review.玻璃体出血中行早期与晚期玻璃体切除术的系统评价
J Clin Med. 2023 Oct 20;12(20):6652. doi: 10.3390/jcm12206652.
2
Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.增生型糖尿病视网膜病变患者行玻璃体切除术治疗后玻璃体积血复发行眼内雷珠单抗与玻璃体切除术治疗的前瞻性研究
Int Ophthalmol. 2020 Apr;40(4):841-847. doi: 10.1007/s10792-019-01244-z. Epub 2019 Dec 2.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial.玻璃体内注射贝伐单抗(IVB)对比玻璃体内注射贝伐单抗联合玻璃体切除术治疗增生性糖尿病视网膜病变继发玻璃体积血:一项随机临床试验。
Int J Retina Vitreous. 2021 Apr 26;7(1):35. doi: 10.1186/s40942-021-00296-7.
5
Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.不伴有视网膜脱离的增生性糖尿病视网膜病变行玻璃体切割联合全视网膜光凝术的疗效:一项七年回顾性研究
Clin Ophthalmol. 2023 Feb 1;17:471-478. doi: 10.2147/OPTH.S400474. eCollection 2023.
6
Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.内切开联合光凝治疗增殖性糖尿病视网膜病变行玻璃体切割术后巩膜切口血管化。
Retina. 2012 Jul;32(7):1310-5. doi: 10.1097/IAE.0b013e318236e7ef.
7
Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.糖尿病 23G 经睫状体平坦部玻璃体切割术后玻璃体积血。
Am J Ophthalmol. 2013 Apr;155(4):757-63, 763.e1-2. doi: 10.1016/j.ajo.2012.11.004. Epub 2013 Jan 11.
8
Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review.玻璃体视网膜手术中的抗血小板药物和抗凝药物:一项系统评价
Life (Basel). 2023 Jun 9;13(6):1362. doi: 10.3390/life13061362.
9
The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.辅助玻璃体内注射贝伐单抗预防增生性糖尿病视网膜病变玻璃体切割术后出血的效果。
Ophthalmology. 2011 Nov;118(11):2218-26. doi: 10.1016/j.ophtha.2011.03.036. Epub 2011 Jul 2.
10
A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India.基于德尔菲法的印度增生性糖尿病视网膜病变手术治疗共识声明。
Indian J Ophthalmol. 2021 Nov;69(11):3308-3318. doi: 10.4103/ijo.IJO_1265_21.

引用本文的文献

1
Brain activity in different brain areas of patients with diabetic vitreous hemorrhage according to voxel-based morphometry.基于体素形态测量法的糖尿病性玻璃体出血患者不同脑区的脑活动情况
Int J Ophthalmol. 2025 Feb 18;18(2):258-267. doi: 10.18240/ijo.2025.02.09. eCollection 2025.
2
Prediction of the Cause of Fundus-Obscuring Vitreous Hemorrhage Using Machine Learning.使用机器学习预测导致眼底模糊的玻璃体积血的病因
Diagnostics (Basel). 2025 Feb 4;15(3):371. doi: 10.3390/diagnostics15030371.
3
Endoscopy-assisted vitrectomy for severe ocular penetrating trauma with corneal opacity.

本文引用的文献

1
Vitreous hemorrhage - Causes, diagnosis, and management.玻璃体积血-病因、诊断和治疗。
Indian J Ophthalmol. 2023 Jan;71(1):28-38. doi: 10.4103/ijo.IJO_928_22.
2
Early vitrectomy in eyes with non-diabetic vitreous hemorrhage.非糖尿病性玻璃体积血患者的早期玻璃体切除术
Ther Adv Ophthalmol. 2022 Apr 29;14:25158414221090099. doi: 10.1177/25158414221090099. eCollection 2022 Jan-Dec.
3
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
内镜辅助玻璃体切除术治疗伴有角膜混浊的严重眼穿通伤
Int J Ophthalmol. 2024 Dec 18;17(12):2256-2264. doi: 10.18240/ijo.2024.12.14. eCollection 2024.
4
Endothelial Cell Changes After Pars Plana Vitrectomy: A Cross-Sectional Study in a Tertiary Care Center.玻璃体切割术后内皮细胞变化:一项在三级医疗中心进行的横断面研究。
Cureus. 2024 Nov 7;16(11):e73250. doi: 10.7759/cureus.73250. eCollection 2024 Nov.
5
A Review of Eales' Disease and .伊尔斯氏病综述与…… (原文不完整,翻译至此)
Biology (Basel). 2024 Jun 20;13(6):460. doi: 10.3390/biology13060460.
玻璃体积血患者增生性糖尿病视网膜病变中玻璃体内注射阿柏西普与全视网膜光凝联合玻璃体切除术对视力的影响:一项随机临床试验。
JAMA. 2020 Dec 15;324(23):2383-2395. doi: 10.1001/jama.2020.23027.
4
Anti-VEGF Therapy or Vitrectomy Surgery for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy.抗血管内皮生长因子治疗或玻璃体切除术治疗增殖性糖尿病视网膜病变所致玻璃体积血
JAMA. 2020 Dec 15;324(23):2375-2377. doi: 10.1001/jama.2020.22829.
5
Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.玻璃体内注射阿柏西普联合全视网膜光凝与早期玻璃体切除术治疗糖尿病性玻璃体积血:随机临床试验。
BMC Ophthalmol. 2020 Apr 6;20(1):130. doi: 10.1186/s12886-020-01401-4.
6
Comparison of outcomes of four different treatment modalities for diabetic vitreous haemorrhage.四种不同治疗方法治疗糖尿病性玻璃体积血的疗效比较。
Sci Rep. 2020 Feb 28;10(1):3674. doi: 10.1038/s41598-020-60378-8.
7
Comparison of Observation Versus Vitrectomy for Patients With Hemorrhagic Posterior Vitreous Detachment.
Ophthalmic Surg Lasers Imaging Retina. 2019 Nov 1;50(11):e288-e293. doi: 10.3928/23258160-20191031-16.
8
Impact of Early Vitrectomy for Dense Vitreous Hemorrhage of Unknown Etiology.不明原因的致密玻璃体出血的早期玻璃体切除术的影响。
Ophthalmologica. 2019;242(4):234-238. doi: 10.1159/000501723. Epub 2019 Sep 3.
9
Clinical features and visual prognostic indicators after vitrectomy for Terson syndrome.特森综合征玻璃体切除术后的临床特征和视觉预后指标。
Eye (Lond). 2020 Apr;34(4):650-656. doi: 10.1038/s41433-019-0547-3. Epub 2019 Aug 27.
10
OUTCOMES OF VITRECTOMY IN TERSON SYNDROME: A Multicenter Canadian Perspective.特森综合征玻璃体切除术的结果:多中心加拿大视角。
Retina. 2020 Jul;40(7):1325-1330. doi: 10.1097/IAE.0000000000002570.